Ad is loading...
TRERX
Price
$14.23
Change
-$0.08 (-0.56%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

TRERX vs VTSNX

Header iconTRERX vs VTSNX Comparison
Open Charts TRERX vs VTSNXBanner chart's image
Nuveen International Eq Retire
Price$14.23
Change-$0.08 (-0.56%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
TRERX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TRERX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRERX is a Buy and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. TRERX (6.47B). VTSNX pays higher dividends than TRERX: VTSNX (3.29) vs TRERX (2.11). TRERX was incepted earlier than VTSNX: TRERX (22 years) vs VTSNX (14 years). TRERX is a more actively managed with annual turnover of: 19.00 vs. VTSNX (4.00). TRERX has a lower initial minimum investment than VTSNX: TRERX (0) vs VTSNX (5000000). TRERX (11.30) and VTSNX (10.92) have marching annual gain over last year. TRERX return over 5 years is better than : 30.42 vs. VTSNX (15.91).
TRERXVTSNXTRERX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years14 years-
Gain YTD4.7094.535104%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.47B442B1%
Annual Yield % from dividends2.113.2964%
Returns for 1 year11.3010.92104%
Returns for 3 years-2.87-5.8649%
Returns for 5 years30.4215.91191%
Returns for 10 years35.0429.81118%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals